).
Click here 
to download the ChemScape Chime plug-in.
Click on this icon
-> 
to download full text papers as .pdf files (Adobe Acrobat). 
Angiogenesis-related papers
|
|
Purine analog 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. | (Abstract) | |
|
|
Human erythropoietin induces a pro-angiogenetic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. | (Abstract) |
|
|
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloprotease-2 secretion parallel progression of human multiple myeloma. | (Abstract) |
|
|
|
Evidence for characteristic vascular patterns in solid tumors: quantitative studies using corrosion casts. | (Abstract) | |
|
|
The biological basis for antiangiogenic therapy (Meeting Report). |
|
|
|
|
Inhibition of Fibroblast Growth Factor-2-induced vascular tumors by the antiviral acyclic nucleoside phosphonate cidofovir. | (Abstract) |
|
|
|
Inhibition of angiogenesis and tumor growth by SCH221153, a dual avb3 and avb5 integrin receptor antagonist. | (Abstract) |
|
|
|
An Italian pioneer in the study of tumor angiogenesis. | (Abstract) |
|
|
The discovery of angiogenic factors: a historical review. | (Abstract) |
|
|
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. | (Abstract) | |
|
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. | (Abstract) | |
|
Anti-angiogenic activity of the purine analog 6-thioguanine | (Abstract) | |
|
Pietro M. Gullino and angiogenesis |
N.
A.
|
|
|
Erythropoietin as an angiogenic factor | (Abstract) | |
|
|
Heparin derivatives as angiogenesis inhibitors |
(Abstract)
|
|
FGF2-related papers
|
|
Identification of Autophosphorylation Sites within Fibroblast Growth Factor (FGF) Receptor-1 Implicated in FGF-mediated Upregulation of Urokinase-Type Plasminogen Activator (uPA): Dissociation of uPA induction from mitogenic signalling. | (Abstract) |
|
|
|
Endothelial Cells Overexpressing Basic Fibroblast Growth Factor (FGF2) Induce Vascular Tumors in Immunodeficient Mice: a Novel Model for the Evaluation of Angiostatic Compounds. | (Abstract) |
|
|
|
avb3 Integrin Mediates the Cell Adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF2) in Cultured Endothelial Cells. | (Abstract) |
|
|
|
Non-Competitive, Chemokine-Mediated Inhibition of Basic Fibroblast Growth Factor-Induced Endothelial Cell Proliferation. | (Abstract) |
|
|
|
Impact of Fibroblast Growth Factor-2 on Tumor Microvascular Architecture: a 3D Morphometric Study. | (Abstract) | |
|
|
Developmentally Regulated Expression and Localization of Fibroblast Growth Factor Receptors in the Human Muscle. | (Abstract) |
|
|
|
Role of Fibroblast Growth Factor-2 in human brain: a focus on development. |
|
|
|
|
Interaction of Fibroblast Growth Factor-2 (FGF-2) with Free Gangliosides: Biochemical Characterization and Biological Consequences in Endothelial Cell Cultures. | (Abstract) |
|
|
|
Role of Endothelial Cell Extracellular Signal-Regulated Kinase-1/2 in Urokinase-Type Plasminogen Activator Upregulation and in vitro Angiogenesis by Fibroblast Growth Factor-2. | (Abstract) |
|
|
|
Modulation of Fibroblast Growth Factor-2 Receptor Binding, Signaling and Mitogenic Activity by Heparin-Mimicking Polysulfonated Compounds. | (Abstract) |
|
|
|
Modulation of tumor angiogenesis by conditional expression of Fibroblast Growth Factor-2 affects early but not established tumors. | (Abstract) |
|
|
|
Paracrine and autocrine effects of Fibroblast Growth Factor-4 in endothelial cells. | (Abstract) |
|
|
|
Fibroblast Growth Factor-2 Antagonist Activity and Angiostatic Capacity of Sulfated Escherichia coli K5 Polysaccharide Derivatives. | (Abstract) |
|
|
|
Fibroblast Growth Factors and their receptors in hematopoiesis and hematological tumors. | (Abstract) |
|
|
Biological activity of substrate-bound basic Fibroblast Growth Factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. | (Abstract) | |
|
|
Gene expression profile in Fibroblast Growth Factor 2-transformed endothelial cells. | (Abstract) |
|
|
Short heparin sequences spaced by glycol-spli uronate residues are antagonists of Fibroblast Growth Factor 2 and angiogenesis inhibitors. | (Abstract) | |
|
Cell membrane GM1 ganglioside is a functional coreceptor for Fibroblast Growth Factor. | (Abstract) | |
|
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 cross-talk in angiogenesis | (Abstract) | |
|
Fibroblast Growth Factor Receptor-1 is essential for in vitro cardiomyocite development | (Abstract) | |
|
|
Distinct role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on tumor growth and angiogenesis | (Abstract) |
|
Chick embryo chorioallantoic membrane-related papers
|
|
New Model for the Study of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane: the Gelatin Sponge/Chorioallantoic Membrane Assay. | (Abstract) | |
|
|
Role of Basic Fibroblast Growth Factor in the Formation of the Capillary Plexus in the Chick Embryo Chorioallantoic Membrane. An in situ Hybridization, Immunohistochemical and Ultrastructural study. | (Abstract) | |
|
|
Alterations of Blood Vessel Development by Fibroblast Growth Factor-2 Overexpressing Endothelial Cells. | (Abstract) |
|
|
|
Endogenous and Exogenous Fibroblast Growth Factor-2 Modulate Wound Healing in the Chick Embryo Chorioallantoic Membrane. | (Abstract) |
|
|
|
Urokinase-Type Plasminogen Activator Induces Neovascularization of the Chick Embryo Chorioallantoic Membrane by Mobilization of Endogenous Fibroblast Growth Factor-2. | (Abstract) |
|
|
|
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. | (Abstract) | |
HIV Tat-related papers
|
|
The Basic Domain of HIV-1 Tat Protein as a Target for Polysulfonated Heparin-Mimicking Extracellular Tat Antagonists. | (Abstract) |
|
|
|
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type-1 Tat protein. | (Abstract) | |
|
|
Thrombospondin-1 Inhibits Kaposi's Sarcoma (KS) Cell and HIV-1 TAT Induced Angiogenesis and Is Poorly Expressed in KS Lesions. | (Abstract) |
|
|
|
Multiple Interactions of HIV-1 Tat Protein with Size-Defined Heparin Oligosaccharides. | (Abstract) |
|
|
|
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat. | (Abstract) |
|
|
|
Activation of endothelial cell mitogen activated protein kinase ERK1/2 by extracellular HIV-1 Tat protein. | (Abstract) | |
|
|
Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans. | (Abstract) |
|
|
HIV-1 Tat protein: a target for the development of anti-AIDS therapies |
(N.A.)
|
|
|
Pentosan polysulfate as inhibitor of extracellular HIV-1 Tat. | (Abstract) | |
|
|
HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies | (Abstract) |
|
Last updated September 23, 2003